Suppression of FLG expression is a well-documented feature in DNCB-induced AD-like mouse skin [12,14]; hence, the FLG reduction was examined in AD-like skin lesions by immunofluorescence staining. The gene discussed is FLG; the disease is Alzheimer disease.